There are 2137 resources available
1790P - Clinical utility of ctDNA and CTCs for genomic profiling and monitoring chemotherapy response in patients with small cell lung cancer
Presenter: Yu Feng
Session: E-Poster Display
Resources:
Abstract
1791P - Effect of anlotinib in advanced small cell lung cancer (SCLC) patients with liver metastases: A subgroup analysis from a randomized, double-blind phase II trial (ALTER 1202)
Presenter: Ying Cheng
Session: E-Poster Display
Resources:
Abstract
1792P - French real world study on patient characteristics and treatment strategies in first-line of extensive-stage small cell lung cancer (ES SCLC)
Presenter: Didier Debieuvre
Session: E-Poster Display
Resources:
Abstract
1793P - RESILIENT part 1: Pharmacokinetics of second-line (2L) liposomal irinotecan in patients with small cell lung cancer (SCLC)
Presenter: Santiago Ponce
Session: E-Poster Display
Resources:
Abstract
1794P - Extensive stage (ES) small-cell lung cancer (SCLC) in Spain: A review of demographic, epidemiological and clinical data from the Thoracic Tumors Registry (TTR study)
Presenter: Virginia Calvo
Session: E-Poster Display
Resources:
Abstract
1795P - Anlotinib combined with etoposide as maintenance treatment in extensive-stage small cell lung cancer (ES-SCLC): A single-arm, prospective phase II study
Presenter: Bo Shen
Session: E-Poster Display
Resources:
Abstract
1796P - Treatment patterns and survival for small cell lung cancer patients: A nationwide Danish register study
Presenter: Anders Green
Session: E-Poster Display
Resources:
Abstract
1797P - Efficacy and safety analysis of EP / EC regimen combined with first-line anlotinib hydrochloride in the treatment of extensive small cell lung cancer: Results from a phase II single-arm trial
Presenter: Tiandong Kong
Session: E-Poster Display
Resources:
Abstract
1798P - Carboplatin-paclitaxel (CP) chemotheraphy as salvage treatment for small cell lung cancer (SCLC): A real-world evidence analysis
Presenter: Alejandro Garcia-Alvarez
Session: E-Poster Display
Resources:
Abstract
1799P - Immune checkpoint inhibitor plus chemotherapy versus chemotherapy alone as first-line for extensive stage small cell lung cancer: A meta-analysis
Presenter: Thierry Landre
Session: E-Poster Display
Resources:
Abstract